Lonza Group AG revenue for the last year amounted to 7.78 B USD, the most of which — 4.14 B USD — came from its highest performing source at the moment, Biologics, the year earlier bringing 3.43 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Lonza Group AG 2.38 B USD, and the year before that — 2.53 B USD.